Advanced Search

    Technical Analysis for PTGX - Protagonist Therapeutics, Inc.

    Grade Last Price % Change Price Change
    A 21.04 -7.48% -1.70
    PTGX closed down 7.48 percent on Wednesday, March 22, 2023, on 55 percent of normal volume.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical PTGX trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    MACD Bearish Signal Line Cross Bearish -7.48%
    1,2,3 Pullback Bullish Bullish Swing Setup -7.48%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -7.48%
    Wide Bands Range Expansion -7.48%
    Outside Day Range Expansion -7.64%
    Wide Bands Range Expansion -7.64%
    1,2,3 Pullback Bullish Bullish Swing Setup -6.16%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -6.16%
    Inside Day Range Contraction -6.16%
    Older End-of-Day Signals for PTGX ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    Down 5% about 12 hours ago
    60 Minute Opening Range Breakdown about 14 hours ago
    Down 3% about 14 hours ago
    Fell Below Previous Day's Low about 14 hours ago
    Down 2 % about 15 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators Basic chart:

    Profile

    Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The Company's initial lead product candidates consists of PTG-100 and PTG-200, which have the potential to transform the existing treatment paradigm for inflammatory bowel disease, a GI disease consisting primarily of ulcerative colitis and Crohn's disease; PTG-300, an injectable hepcidin mimetic. Protagonist Therapeutics, Inc. is based in Milpitas, United States.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Immunology Autoimmune Disease Proprietary Technology Inflammatory Bowel Disease Ulcer Ulcerative Colitis Colitis Abdominal Pain Crohn's Disease Chemical Entities Gi Disease Hepcidin

    Is PTGX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 21 Strength Seen in Nurix Therapeutics, Inc. (NRIX): Can Its 5.7% Jump Turn into More Strength?
    Mar 20 Analysts Just Made A Major Revision To Their Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Revenue Forecasts
    Mar 17 Protagonist Therapeutics (NASDAQ:PTGX) Is In A Good Position To Deliver On Growth Plans
    Mar 15 Protagonist GAAP EPS of -$0.69 misses by $0.10
    Mar 15 Protagonist Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
    Mar 15 Protagonist Therapeutics Touts Positive Data From Bone Marrow Disorder Study
    Mar 15 Protagonist Therapeutics Announces Highly Statistically Significant Results from the Randomized Withdrawal Portion of the REVIVE Study of Rusfertide in Polycythemia Vera
    Mar 14 Top 5 Health Care Stocks That Are Ticking Portfolio Bombs
    Mar 9 Biotech Stock Roundup: PTGX Gains on Study Data, BMRN Faces Setback & More
    Mar 9 Protagonist Therapeutics: More Good News Likely To Come
    See more PTGX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 25.97
    52 Week Low 6.91
    Average Volume 1,810,984
    200-Day Moving Average 10.87
    50-Day Moving Average 16.66
    20-Day Moving Average 20.55
    10-Day Moving Average 23.61
    Average True Range 1.50
    RSI 54.95
    ADX 45.64
    +DI 28.71
    -DI 23.58
    Chandelier Exit (Long, 3 ATRs) 21.19
    Chandelier Exit (Short, 3 ATRs) 19.51
    Upper Bollinger Bands 28.32
    Lower Bollinger Band 12.77
    Percent B (%b) 0.53
    BandWidth 75.69
    MACD Line 1.98
    MACD Signal Line 2.22
    MACD Histogram -0.2404
    Fundamentals Value
    Market Cap 804.92 Million
    Num Shares 38.3 Million
    EPS -2.74
    Price-to-Earnings (P/E) Ratio -7.67
    Price-to-Sales 26.02
    Price-to-Book 4.80
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 23.61
    Resistance 3 (R3) 23.88 23.29 23.18
    Resistance 2 (R2) 23.29 22.64 23.16 23.03
    Resistance 1 (R1) 22.17 22.24 21.88 21.90 22.89
    Pivot Point 21.58 21.58 21.44 21.45 21.58
    Support 1 (S1) 20.46 20.93 20.17 20.19 19.19
    Support 2 (S2) 19.87 20.53 19.74 19.05
    Support 3 (S3) 18.75 19.87 18.90
    Support 4 (S4) 18.48